Biomed Industries Advances Next-Generation Oral Weight-Loss Pill into Phase 3 Trials

New Orleans, Wednesday, 10 June 2026.
Biomed Industries announced Phase 3 trials at ADA 2026 for a groundbreaking oral weight-loss pill that burns fat, preserves muscle mass, and offers long-term maintenance after stopping traditional injections.